Sort
48,018 grants matching “immunotherapy”
Developmental Core
$1,033,694Elizabeth A Klonoff · San Diego State University · U54 · FY2010 · CA
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
$1,033,264Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · R35 · FY2020 · CA
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
$1,032,791Brian Till · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,032,476Johns Hopkins University · U01 · FY2004 · AI
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
$1,032,278Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · CA
Cancer Biomaterials Engineering
$1,031,635Matthew Wolf · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
SBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy
$1,031,566Ming Yang · Mucommune, Llc · R44 · FY2025 · CA
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
$1,031,487Scarlett L Gomez · University Of California, San Francisco · R01 · FY2022 · CA
DNA Vaccines
$1,031,160George N. Pavlakis · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
ANTIGEN-SPECIFIC VACCINES FOR BREAST CANCER
$1,030,900Johns Hopkins University · U19 · FY2002 · CA
IMPROVING CORD BLOOD TRANSPLANTATION
$1,030,855Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis
$1,030,688Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Liver Cancer Program
$1,030,084Anuradha Budhu · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis
$1,028,402Claudia Cicala · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Targeted immune therapies in heart transplantation
$1,028,140Reza Abdi · Brigham And Women'S Hospital · R35 · FY2024 · HL
CLINICAL INVESTIGATION OF ACTIVE SPECIFIC IMMUNOTHERAPY OF MALIGNANT MELANOMA
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
CHARACTERIZATION OF TUMOR ANTIGENS THAT ELICIT HUMORAL IMMUNE RESPONSES IN MAN
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
MARKERS TO IMPROVE ASSESSMENT OF TREATMENT EFFICACY FOR METASTATIC MELANOMA
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
Integrating targeted therapy and immunotherapy to break through cancer
$1,027,633Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Integrating targeted therapy and immunotherapy to break through cancer
$1,027,633Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Clinical Analysis Of Disorders Of Hearing And Balance
$1,027,414Carmen Crowell Brewer · National Institute On Deafness And Other Communication Disorders · ZIA · FY2012 · DC
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
$1,027,367William C Hahn · Dana-Farber Cancer Inst · U01 · FY2017 · CA
IL-15 in the immunotherapy of cancer
$1,026,376Kevin Conlon · Division Of Basic Sciences - Nci · ZID · FY2014 · CA
Leadership, Planning, and Evaluation
$1,026,251Ramesh A Shivdasani · Dana-Farber Cancer Inst · P30 · FY2025 · CA
Los Angeles Pediatric AIDS Clinical Trials Unit
$1,026,140University Of California Los Angeles · U01 · FY2002 · AI